Detail akcie Iridex Corp online

Business Summary: IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Financial Summary: BRIEF: For the nine months ended 27 September 2025, IRIDEX Corp revenues increased 5% to $38M. Net loss decreased 47% to $4.3M. Revenues reflect Retina segment increase of 4% to $21.4M, G6 segment increase of 6% to $10M, Europe & Middle East & Africa segment increase of 15% to $10.5M, Asia/Pacific Rim segment increase of 4% to $9.1M. Lower net loss reflects Selling/General/Admin. Expense decrease of 23% to $7.5M (expense).